Your institution may have access to this item. Find your institution then sign in to continue.
Title
New molecular entity.
Abstract
The article discusses Xenazine, a tetrabenazine drug from Biovail and Ovation. According to that author, tetrabenazine is approved by the Food and Drug Administration for treating chorea, a disease associated with Huntington's disease. A controlled study was used to test the efficacy of the said drug. Lastly, details on the dosing of the drug are also included in the article.